Clinical Trials and Research
The Center for Research on Women’s Health and Reproductive Medicine is currently conducting the following clinical research studies in reproductive medicine:
Fragile X Premutations Among Women With Infertility
The purpose of this research study is to see how common the Fragile X (FMR1) premutation is in women with a particular infertility-related ovarian condition called “diminished ovarian reserve”. Genes contain instructions that tell our bodies how to develop and function properly. The blood test used in this study will look for a specific genetic abnormality (called “fragile X or FMR1 premutation”) that may indicate an increased chance for developing premature depletion of eggs, early menopause and, infertility. Stanford University and the University of Virginia are collaborating on this study. Enrolled participants will receive a $50 gift card and free genetic testing. Those participants who wish to learn the results of their genetic testing will also receive genetic counseling free of charge. See details. Please contact Angie Morey for additional information.
Tracy Lindsay
Clinical Research Coordinator
tracyl@stanford.edu
(650) 498-7408